v3.26.3
EQUITY METHOD INVESTMENT
9 Months Ended
Sep. 30, 2026
Equity Method Investments and Joint Ventures [Abstract]  
EQUITY METHOD INVESTMENT
NOTE 6. EQUITY METHOD INVESTMENT

Following the Deconsolidation Transaction on June 3, 2026, the Company retained an investment in Harvest consisting of 100% of the Non-Voting Units, which do not carry voting rights or rights to receive dividends, do not provide the Company with the ability to direct the business, operations or activities of Harvest, or provide other rights upon dissolution of Harvest, and which are only convertible into the Common Units following the Stock Exchange Permissibility Date, and therefore do not currently provide the Company with a controlling financial interest.

The Company evaluated Harvest under ASC 810 and concluded that Harvest is a variable interest entity ("VIE"). Although the Company holds a variable interest through its Non-Voting Units, the Company determined that it is not the primary beneficiary because it does not possess the authority to direct the activities that most significantly affect Harvest’s economic performance. Accordingly, the Company does not consolidate Harvest.

The Company concluded that it possesses significant influence over Harvest through its board representation, participation in strategic and operating policy decisions, and other governance rights. Accordingly, the retained investment is accounted for under the equity method pursuant to ASC 323.

Upon deconsolidation, the Company recognized its retained 90% equity interest in Harvest at fair value in accordance with ASC 810-10-40. The resulting fair value became the initial carrying amount of the Company’s equity method investment. The fair value of the retained investment was determined using a combination of the income approach and market approach, including consideration of discounted cash flow analyses, market multiples of comparable publicly traded companies, and other relevant market data. Significant unobservable inputs utilized in the valuation included an 11.0% discount rate, projected EBITDA margins ranging from approximately 22.8% to 25.1%, and a 23.5% discount for lack of marketability. Due to the valuation incorporating significant unobservable inputs and management estimates, the fair value measurement was classified as a Level 3 fair value measurement. The carrying amount of the investment is subsequently adjusted for the Company’s proportionate share of Harvest’s earnings (losses). The Company recognized its equity in net loss of Harvest of approximately $6.4 million for the three months ended September 30, 2026, and approximately $9.7 million for the nine months ended September 30, 2026, which are presented within Equity in net loss of Harvest in the condensed consolidated statements of operations. As of September 30, 2026, the carrying amount of the Company’s equity method investment was approximately $146.1 million.

The purchase price allocation remains preliminary as Harvest completes its fair value assessments of acquired intangible assets, inventory, and property, plant and equipment. Measurement-period adjustments to these preliminary amounts may impact depreciation, amortization, cost of goods sold and other amounts recognized in the current and future periods.

The Company continually evaluates its equity method investment for indicators of impairment. If events or changes in circumstances indicate that the investment has experienced an other-than-temporary decline in value, the Company records an impairment charge equal to the amount by which the carrying amount exceeds its estimated fair value. No impairment indicators were identified during the three and nine months ended September 30, 2026.

The Company has entered into certain commercial agreements with Harvest, including the MSA pursuant to which the Company provides specified consulting, advisory and administrative support services. Transactions under these arrangements are conducted pursuant to contractual terms.

The Company’s maximum exposure to loss associated with Harvest was approximately $167.3 million as of September 30, 2026, representing the carrying amount of its equity method investment and the outstanding MSA receivable. The Company has not guaranteed Harvest’s obligations, provided debt guarantees, entered into liquidity arrangements, or committed to provide additional financial support to Harvest.